Published in Physician Law Weekly, September 8th, 2004
While profits may not skyrocket, the development can certainly give the industry a boost.
New analysis from Frost & Sullivan, "Changing Role of Medicare and its Impact on Pharmaceutical Companies," reveals that the Medicare spending grew at a rate of 5.7% in 2003. It is likely to grow at a CAGR of 9.2% from 2003 to 2010.
Pharmacy benefit managers (PBM) and private insurance providers are likely to be among the first to tackle the effects of the law changes. They have to draw on all...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.